Clinical Trials for Mogad? What Are Your Thoughts?

Mogad is entering an age f clinical trials for mogad. In many cases, the lesions tending to resolve completely. So how might this affect what we do for clinical trials? We don't know exactly why the mag antibody lesions resolve completely. But when we look pathologically at mag antibodya diseased lesions, we tend to see demilination. Maybe if we learned more about that, it could have applications for a treatment for m s in the future.